FDA, Industry, Regulations, Vaccines
June 10, 2024
Via: Drugs.comThe U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. Drugmaker GSK’s Arexvy vaccine, […]
February 9, 2023
Via: Drugs.comFor the first time, COVID-19 vaccines have been added to the list of routine immunizations recommended for adults — a further sign the virus is here to stay. The addition is being made to the 2023 Recommended Adult Immunization Schedule, […]
July 19, 2024
July 11, 2024
July 11, 2024
Copyright © 2024. All rights reserved
